POSTER SESSION VI
Wednesday, March 2, 2011 — 1:00 PM - 4:00 PM
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
BREAST PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
1
Clinicopathologic Analysis of Low Grade Invasive Breast Carcinomas (BC) with intermediate and High Oncotype DX Recurrence Scores.
(95)
G Acs, NN Esposito, C Laronga - Ruffolo Hooper & Associates, Tampa, FL; Moffitt Cancer Center, Tampa, FL
HER3 Expression in Human Breast Carcinomas Is Associated with Tumor Size, Lymph Node Metastasis and Estrogen Receptor Status.
(266)
C Teixido, V Peg, T Moline, M Sanchez-Martin, A Pandiella, S Ramon y Cajal, J Hernandez-Losa - Vall Hebron University Hospital, Barcelona, Spain; Center for Cancer investigation, Salamanca, Spain
MDGI, MIG-6 and EIG-121 Are Negative Regulators in EGFR Trafficking and Potential Biomarkers to EGFR Inhibitor Therapy in Triple-Negative Breast Carcinomas.
(216)
D Meseure, S Vacher, K Drak Alsibai, M Trassard, F Lerebours, JM Guinebretiere, R Lidereau, I Bieche - Institut Curie, Hopital Rene Huguenin, St Cloud, France
Prognostic Significance of PIK3CA Mutations and Immunophenotypes in Lymph Node-Positive Breast Carcinomas.
(99)
FI Aranda, L Sanchez-Tejada, C Alenda, G Peiro, J Segui, M Niveiro, A Paya, JB Laforga, E de Alava, J Palacios, M Martin - Hospital General Universitario, Alicante, Spain; Centro Investigacion del Cancer, Salamanca, Spain; Hospital Virgen del Rocio, Sevilla, Spain; GEICAM, Madrid, Spain
Comparison of Protein Expression and Molecular Subtype in Breast Cancer before and after Neoadjuvant Chemotherapy.
(199)
H-C Lee, H Seol, H Ko, IA Park - Seoul National University College of Medicine, Republic of Korea; Chungbuk National University College of Medicine, Cheongju, Republic of Korea
Analysis of Class III Beta Tubulin by Molecular Subtype in Breast Cancer . A Pilot Study.
(278)
Y Wang, J Sparano, J Sunkara, S Horwitz, H McDaid - Albert Einstein College of Medicine, Bronx, NY
High Expression of DCN and HSP90B1 in Breast Cancer Is Associated with LN and Distant Metastases and Decreased Overall Survival.
(220)
JC Moreno, D Tran-Thanh, T Cawthorn, L Jacks, S Ackloo, P Hong Zhu, M Dharsee, G Sardana, J Chen, KR Evans, D McCready, WL Leong, SJ Done - Campbell Family Institute for Breast Cancer Research, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada; University of Toronto, ON, Canada; Ontario Cancer Biomarker Network, Toronto, Canada
Does PTEN Loss and Activation of the mTOR Pathway Underlie Breast Cancer Metastases?
(296)
R Zheng, A Cimino-Mathews, B Gurel, AM De Marzo, J Hicks, P Argani - Johns Hopkins, Baltimore, MD
The Expression of Tocopherol Associated Protein (TAP) Is Associated with Recurrence and Survival Rates in Node Positive Breast Cancer Patients.
(277)
X Wang, B Ring, D Hicks, S Yeh, K Woolf, R Beck - University of Rochester Medical Center, NY; Clarient Institute, Huntsville
The Association between Vascular Endothelial Growth Factor (VEGF) Expression and Outcome in Invasive Breast Cancer Is Modified by Intrinsic Subtype: Results from the Nurses' Health Study.
(158)
H Gilmore, Y Liu, R Tamimi, S Schnitt, G Colditz, L Collins - Beth Israel Deaconess Medical Center, Boston; Washington University School of Medicine, St. Louis; Channing Laboratory, Brigham and Women's Hospital, Boston
The Diagnostic Utility of the "Minimal Carcinoma (MC) Triple Stain" in Breast Carcinomas.
(245)
DS Ross, Y-F Liu, J Pipa, SJ Shin - Weill Cornell Medical College, New York, NY
Interaction of Upstream Stimulatory Factor 2 and FOXA1 in Breast Cancer.
(178)
RK Jain, R Mehta, PM Sojitra, H Nakshatri, S Badve - Indiana University School of Medicine, Indianapolis
Regulatory T-Cells in Breast Cancer Sentinel Nodes: FOXP3 Expression Analysis.
(259)
PM Sojitra, M Thorat, RK Jain, R Mehta, S Badve - Indiana University School of Medicine, Indianapolis
Bcl-2 Expression in Different Mammary Carcinoma Subtypes. Correlation with Nottingham Histologic Grade.
(201)
M Lioni, R Bhat, S Cavone, F Garcia - Drexel University College of Medicine, Philadelphia, PA
Glucocorticoid Receptor Expression in Breast Carcinoma Molecular Subtypes: An Immunohistochemical Study.
(258)
K Singh, S Lu, L Noble, R Tavares, R DeLellis, M Resnick, E Yakirevich - Rhode Island Hospital/Alpert Medical School of Brown University, Providence
Higher Levels of GATA3 Predict Better Survival in Women with Breast Cancer.
(254)
D Shen, NK Yoon, EL Maresh, Y Elshimali, S Apple, S Horvath, V Mah, S Bose, D Chia, HR Chang, L Goodglick - Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; UCLA David Geffen School of Medicine, Los Angeles, CA; Cedars Sinai Medical Center, Los Angeles, CA
Expression of Transcription Factors [FOXA1-GATA3] in ER-Positive Node-Negative Breast Cancer.
(109)
OL Bohn, G Carter, A Brusky, R Jankowitz, P Badve, M Chivukula - MetroHealth Medical Center, Cleveland, OH; Magee-Womens Hospital UPMC, Pittsburgh, PA
Metadherin (MTDH/AEG1): A Novel Marker for Metastasis and Chemoresistance Expression in Lymphnode Negative(LN -), Estrogen Receptor Positive (ER+) Breast Cancer Women.
(125)
M Chivukula, A Brufsky, R Jankowitz, K Mcmanus, G Carter - Magee Women's Hospital of UPMC, Pittsburgh, PA
Immunohistochemical Staining Patterns of Low-Grade Adenosquamous Carcinoma (LGASC) Different from Other Small Glandular Proliferations of the Breast (SGPB).
(187)
K Kawaguchi, SJ Shin - Weill Cornell Medical College, New York, NY
The Evaluation of the Breast Biomarkers in Multifocal/Multicentric Breast Carcinomas.
(231)
M Pekmezci, A Salhadar, P Rajan, C Ersahin - Loyola University Medical Center, Maywood, IL
Calreticulin Expression in Breast Cancer: Correlation with Prognostic Factors.
(107)
SL Bohman, C Cohen, G Oprea, HC Sullivan, B Zbytek, A Adams - Emory University, Atlanta, GA
Syndecan-1/CD138 Expression in Triple Negative Breast Carcinoma.
(172)
AL Husman, AL Adams, C Cohen, AJ Page, HC Sullivan, GM Oprea - Emory University, Atlanta, GA
Clinical Utility of a p63-CK7/18-CK5/14 Antibody Cocktail in Diagnostic Breast Pathology.
(238)
ES Reisenbichler, JR Ross, O Hameed - University of Alabama at Birmingham
Src Expression in Infiltrating Breast Carcinoma with Hormone Receptor Positive: Prognostic Significance.
(221)
TA Muci, L Sanchez-Tejada, C Alenda, M Niveiro, J Segui, G Peiro, FI Aranda - Hospital General Universitario, Alicante, Spain
Osteopontin and Osteopontin-c Protein and mRNA Expression Correlate with Breast Cancer Aggressiveness.
(230)
G Peiro, F Ortiz-Martinez, E Lerma, E Adrover, M Planelles, L Sanchez-Tejada, FI Aranda, FJ Gutierrez-Avino, D Giner - Hospital General Universitari d'Alacant, Spain; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
button next to any title to add to Itinerary Planner...
Add
